Chamoto K - Search Results

1

Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy.

Chowdhury PS, Chamoto K, Honjo T. Chowdhury PS, et al. Among authors: chamoto k. J Intern Med. 2018 Feb;283(2):110-120. doi: 10.1111/joim.12708. Epub 2017 Nov 16. J Intern Med. 2018. PMID: 29071761 Review.

2

PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8⁺ T Cells and Facilitates Anti-PD-1 Therapy.

Chowdhury PS, Chamoto K, Kumar A, Honjo T. Chowdhury PS, et al. Among authors: chamoto k. Cancer Immunol Res. 2018 Nov;6(11):1375-1387. doi: 10.1158/2326-6066.CIR-18-0095. Epub 2018 Aug 24. Cancer Immunol Res. 2018. PMID: 30143538

3

Erratum to: Role of PD-1 in Immunity and Diseases.

Chamoto K, Al-Habsi M, Honjo T. Chamoto K, et al. Curr Top Microbiol Immunol. 2017;410:E1. doi: 10.1007/978-3-319-68929-6_69. Curr Top Microbiol Immunol. 2017. PMID: 29492725 No abstract available.

4

Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior.

Miyajima M, Zhang B, Sugiura Y, Sonomura K, Guerrini MM, Tsutsui Y, Maruya M, Vogelzang A, Chamoto K, Honda K, Hikida T, Ito S, Qin H, Sanuki R, Suzuki K, Furukawa T, Ishihama Y, Matsuda F, Suematsu M, Honjo T, Fagarasan S. Miyajima M, et al. Among authors: chamoto k. Nat Immunol. 2017 Dec;18(12):1342-1352. doi: 10.1038/ni.3867. Epub 2017 Oct 23. Nat Immunol. 2017. PMID: 29058703

5

Role of PD-1 in Immunity and Diseases.

Chamoto K, Al-Habsi M, Honjo T. Chamoto K, et al. Curr Top Microbiol Immunol. 2017;410:75-97. doi: 10.1007/82_2017_67. Curr Top Microbiol Immunol. 2017. PMID: 28929192 Review.

6

Cancer immunotherapies targeting the PD-1 signaling pathway.

Iwai Y, Hamanishi J, Chamoto K, Honjo T. Iwai Y, et al. Among authors: chamoto k. J Biomed Sci. 2017 Apr 4;24(1):26. doi: 10.1186/s12929-017-0329-9. J Biomed Sci. 2017. PMID: 28376884 Free PMC article. Review.

7

[Immune checkpoint inhibitors targeting programmed cell death-1 (PD-1) in cancer therapy].

Hatae R, Chamoto K. Hatae R, et al. Among authors: chamoto k. Rinsho Ketsueki. 2016;57(10):2224-2231. doi: 10.11406/rinketsu.57.2224. Rinsho Ketsueki. 2016. PMID: 27795534 Japanese.

8

Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity.

Chamoto K, Chowdhury PS, Kumar A, Sonomura K, Matsuda F, Fagarasan S, Honjo T. Chamoto K, et al. Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E761-E770. doi: 10.1073/pnas.1620433114. Epub 2017 Jan 17. Proc Natl Acad Sci U S A. 2017. PMID: 28096382 Free PMC article.

9

VISTA expressed in tumour cells regulates T cell function.

Mulati K, Hamanishi J, Matsumura N, Chamoto K, Mise N, Abiko K, Baba T, Yamaguchi K, Horikawa N, Murakami R, Taki M, Budiman K, Zeng X, Hosoe Y, Azuma M, Konishi I, Mandai M. Mulati K, et al. Among authors: chamoto k. Br J Cancer. 2019 Jan;120(1):115-127. doi: 10.1038/s41416-018-0313-5. Epub 2018 Nov 9. Br J Cancer. 2019. PMID: 30382166 Free PMC article.

10

Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma.

Goto M, Chamoto K, Higuchi K, Yamashita S, Noda K, Iino T, Miura M, Yamasaki T, Ogawa O, Sonobe M, Date H, Hamanishi J, Mandai M, Tanaka Y, Chikuma S, Hatae R, Muto M, Minamiguchi S, Minato N, Honjo T. Goto M, et al. Among authors: chamoto k. Sci Rep. 2019 Jul 12;9(1):10144. doi: 10.1038/s41598-019-46548-3. Sci Rep. 2019. PMID: 31300681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results